NATH BIOGENES (INDIA)
Back to Cashflow Statement
|
NATH BIOGENES (INDIA) Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-2.13 Cr | ₹-7.78 Cr | ₹-1.67 Cr | ₹-22 Cr | ₹5.74 Cr |
What is the latest Cash Flow from Financing Activities ratio of NATH BIOGENES (INDIA) ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-2.13 Cr |
| Mar2024 | ₹-7.78 Cr |
| Mar2023 | ₹-1.67 Cr |
| Mar2022 | ₹-22 Cr |
| Mar2013 | ₹5.74 Cr |
How is Cash Flow from Financing Activities of NATH BIOGENES (INDIA) Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-2.13 Cr | Negative | |
| Mar2024 | ₹-7.78 Cr | Negative | |
| Mar2023 | ₹-1.67 Cr | Negative | |
| Mar2022 | ₹-22 Cr | Negative | |
| Mar2013 | ₹5.74 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹294.0 Cr | 8% | -6% | -25.6% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹13,043.2 Cr | 3.1% | -0.3% | -21.8% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,978.0 Cr | 2% | -9.4% | 2.9% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,003.9 Cr | 4.8% | 5.4% | -20.8% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,032.3 Cr | 0.2% | -16.1% | -39.6% | Stock Analytics | |
| INDO US BIOTECH | ₹250.9 Cr | -2.5% | -3.8% | -55.7% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | 8% |
-6% |
-25.6% |
| SENSEX | -0.5% |
1% |
4.6% |
You may also like the below Video Courses